These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8202971)

  • 21. Changes in tardive dyskinesia symptoms in elderly patients treated with ganglioside GM1 or placebo.
    Sommer BR; Cohen BM; Satlin A; Cole JO; Jandorf L; Dorsey F
    J Geriatr Psychiatry Neurol; 1994; 7(4):234-7. PubMed ID: 7826493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients.
    Schneider JS; Gollomp SM; Sendek S; Colcher A; Cambi F; Du W
    J Neurol Sci; 2013 Jan; 324(1-2):140-8. PubMed ID: 23199590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group.
    Grotta J
    Stroke; 1997 Dec; 28(12):2338-46. PubMed ID: 9412611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and baseline results of the monosialoganglioside early stroke trial. The EST Study Group.
    Rocca WA; Dorsey FC; Grigoletto F; Gent M; Roberts RS; Walker MD; Easton JD; Bruno R; Carolei A; Sancesario G
    Stroke; 1992 Apr; 23(4):519-26. PubMed ID: 1561683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside.
    Geisler FH; Dorsey FC; Coleman WP
    N Engl J Med; 1991 Jun; 324(26):1829-38. PubMed ID: 2041549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common drugs may influence motor recovery after stroke. The Sygen In Acute Stroke Study Investigators.
    Goldstein LB
    Neurology; 1995 May; 45(5):865-71. PubMed ID: 7746398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
    Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ganglioside GM1 in early strokes].
    Kuczyńska-Zardzewiały A; Kruszewska J; Lechowicz W; Członkowska A
    Neurol Neurochir Pol; 1994; 28(5):643-9. PubMed ID: 7862232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trial of ganglioside GM1 in acute stroke.
    Appollonio I; Frattola L; Massarotti M
    J Neurol Neurosurg Psychiatry; 1989 May; 52(5):685-6. PubMed ID: 2732750
    [No Abstract]   [Full Text] [Related]  

  • 31. GM1 ganglioside treatment of spontaneously hypertensive stroke prone rats.
    Hernandez NE; MacDonall JS; Stier CT; Belmonte A; Fernandez R; Karpiak SE
    Exp Neurol; 1994 Mar; 126(1):95-100. PubMed ID: 8157130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.
    Donnan GA; Davis SM; Chambers BR; Gates PC; Hankey GJ; McNeil JJ; Rosen D; Stewart-Wynne EG; Tuck RR
    JAMA; 1996 Sep; 276(12):961-6. PubMed ID: 8805730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke.
    Dyker AG; Lees KR
    Stroke; 1999 Sep; 30(9):1796-801. PubMed ID: 10471426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind evaluation of monosialoganglioside (GM1) therapy in stroke.
    Bassi S; Albizzati MG; Sbacchi M; Frattola L; Massarotti M
    J Neurosci Res; 1984; 12(2-3):493-8. PubMed ID: 6389896
    [No Abstract]   [Full Text] [Related]  

  • 35. DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke.
    Diener HC; Schneider D; Lampl Y; Bornstein NM; Kozak A; Rosenberg G
    Stroke; 2008 Jun; 39(6):1774-8. PubMed ID: 18403736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial.
    Shyu WC; Lin SZ; Lee CC; Liu DD; Li H
    CMAJ; 2006 Mar; 174(7):927-33. PubMed ID: 16517764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. European and Australian Lubeluzole Ischaemic Stroke Study Group.
    Diener HC
    Cerebrovasc Dis; 1998; 8(3):172-81. PubMed ID: 9619701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the ganglioside GM1 on neurologic function, electroencephalogram amplitude, and histology in chronic middle cerebral artery occlusion in cats.
    Komatsumoto S; Greenberg JH; Hickey WF; Reivich M
    Stroke; 1988 Aug; 19(8):1027-35. PubMed ID: 3400101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
    Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GM1 gangliosides in the treatment of spinal cord injury: report of preliminary data analysis.
    Geisler FH; Dorsey FC; Coleman WP
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):515-21. PubMed ID: 2130666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.